Toronto, ON
Canada
12
2013-03-21
10
2014-05-27
These are the the leading inventors for applications assigned to APOTEX TECHNOLOGIES INC.:
APOTEX TECHNOLOGIES INC. based in Toronto, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
#2 | 2013-03-07 ✅ Patent 8,507,449 granted on 2013-08-13Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#3 | 2013-03-07 ✅ Patent 8,476,235 granted on 2013-07-02Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#4 | 2013-02-21 ✅ Patent 8,481,588 granted on 2013-07-09Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#5 | 2013-02-21 ✅ Patent 8,664,262 granted on 2014-03-04Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#6 | 2013-01-24Use of Deferiprone for Treatment and Prevention of Iron-Related Eye Disorders
#7 | 2013-01-03 ✅ Patent 8,592,607 granted on 2013-11-26Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#8 | 2011-10-06METHOD AND APPARATUS FOR PACKAGING AND DISPENSING PHARMACEUTICALS
#9 | 2011-02-17 ✅ Patent 8,703,156 granted on 2014-04-22Liquid formulation for deferiprone with palatable taste
#10 | 2010-03-04 ✅ Patent 8,138,221 granted on 2012-03-20Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
#11 | 2010-02-04 ✅ Patent 8,207,217 granted on 2012-06-26Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#12 | 2010-01-21 ✅ Patent 8,119,606 granted on 2012-02-21Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
6113 ⎘